Stryker Croissance future

Future contrôle des critères 2/6

Stryker devrait augmenter ses bénéfices et son chiffre d'affaires de 11.2% et de 7.4% par an respectivement. Le BPA devrait croître de de 11.5% par an. Le rendement des capitaux propres devrait être 22% dans 3 ans.

Informations clés

11.2%

Taux de croissance des bénéfices

11.5%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices	17.4%
Taux de croissance des recettes	7.4%
Rendement futur des capitaux propres	22.0%
Couverture par les analystes	Good
Dernière mise à jour	05 Nov 2024

Mises à jour récentes de la croissance future

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

Prévisions de croissance des bénéfices et des revenus

NYSE:SYK - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	26,272	4,926	4,762	5,515	25
12/31/2025	24,393	4,430	4,355	5,044	28
12/31/2024	22,517	3,768	3,355	3,723	25
9/30/2024	21,974	3,590	3,205	3,839	N/A
6/30/2024	21,389	3,448	2,803	3,415	N/A
3/31/2024	20,963	3,361	2,858	3,470	N/A
12/31/2023	20,498	3,165	3,136	3,711	N/A
9/30/2023	19,885	2,585	2,568	3,186	N/A
6/30/2023	19,455	2,709	2,417	3,025	N/A
3/31/2023	18,952	2,627	2,267	2,866	N/A
12/31/2022	18,449	2,358	2,036	2,624	N/A
9/30/2022	17,948	2,457	2,015	2,621	N/A
6/30/2022	17,629	2,079	2,067	2,665	N/A
3/31/2022	17,430	2,015	2,453	3,014	N/A
12/31/2021	17,108	1,994	2,738	3,263	N/A
9/30/2021	16,669	1,900	3,016	3,500	N/A
6/30/2021	16,246	2,083	2,973	3,396	N/A
3/31/2021	14,716	1,408	2,712	3,138	N/A
12/31/2020	14,351	1,599	2,790	3,277	N/A
9/30/2020	14,220	1,756	2,254	2,775	N/A
6/30/2020	14,070	1,601	1,960	2,575	N/A
3/31/2020	14,956	2,164	1,798	2,469	N/A
12/31/2019	14,884	2,083	1,542	2,191	N/A
9/30/2019	14,549	3,426	1,898	2,502	N/A
6/30/2019	14,204	3,550	1,910	2,491	N/A
3/31/2019	13,876	3,522	2,053	2,626	N/A
12/31/2018	13,601	3,553	2,038	2,610	N/A
9/30/2018	13,276	1,236	1,639	2,243	N/A
6/30/2018	13,040	1,080	N/A	1,704	N/A
3/31/2018	12,730	1,019	N/A	1,705	N/A
12/31/2017	12,444	1,020	N/A	1,559	N/A
9/30/2017	12,130	1,779	N/A	1,538	N/A
6/30/2017	11,957	1,700	N/A	1,961	N/A
3/31/2017	11,785	1,689	N/A	1,804	N/A
12/31/2016	11,325	1,647	N/A	1,915	N/A
9/30/2016	10,883	1,659	N/A	1,928	N/A
6/30/2016	10,470	1,605	N/A	917	N/A
3/31/2016	10,062	1,617	N/A	781	N/A
12/31/2015	9,946	1,439	N/A	981	N/A
9/30/2015	9,849	1,177	N/A	907	N/A
6/30/2015	9,818	933	N/A	1,940	N/A
3/31/2015	9,749	669	N/A	1,953	N/A
12/31/2014	9,675	515	N/A	1,782	N/A
9/30/2014	9,525	641	N/A	1,775	N/A
6/30/2014	9,287	687	N/A	1,873	N/A
3/31/2014	9,136	772	N/A	1,859	N/A
12/31/2013	9,021	1,006	N/A	1,886	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de SYK ( 11.2% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de SYK ( 11.2% par an) devraient croître plus lentement que le marché US ( 15.4% par an).

Croissance élevée des bénéfices: Les bénéfices de SYK devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de SYK ( 7.4% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de SYK ( 7.4% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de SYK devrait être élevé dans 3 ans ( 22 %)

Stryker Croissance future

Future contrôle des critères 2/6

Informations clés

Mises à jour récentes de la croissance future

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Recent updates

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year